Will Healy

Will Healy

Will Healy is a freelance financial writer. He had a lifelong interest in the stock market, trading equities since the dot-com boom. Will pursued his passion for writing after working in the corporate world as both an analyst and an insurance sales professional. He likes to approach the market by focusing on deep value, dividends, and speculation.

Will’s writing has focused on stock analysis, as well as real estate, insurance, personal finance, macroeconomics, and politics. Along with InvestorPlace, his work has appeared on numerous sites, including Seeking Alpha, Yahoo! Finance, MSN Money, Kiplinger Tax Letter, and GOBankingRates. He holds both a B.S. in Journalism and an MBA in finance and strategy.

Recent Articles

Red Hat Purchase Makes IBM Stock Speculative Dividend Play

It will take time to know whether Red Hat rescues IBM stock, making the rising dividend lucrative but more difficult to maintain.

Intel Stock Still Has a Little Room for Growth Left

Despite surge, Intel stock remains a long-term buy, but history shows that traders should exercise caution in buying on trade talk hopes.

Alphabet Stock Suffers from Having Too Much of Its Value Locked Up

Accusations of lax data privacy protections have hurt Alphabet stock, but unlocking value in the company could help rescue GOOGL.

Nio Stock Shows Little Potential for Getting out of Reverse

Poor sales and massive losses continue to drive Nio stock, and by all indications, NIO appears poised to continue on its current path.

The Rally of Snap Stock Could Disappear Faster Than a Snapchat Photo

SNAP stock has rallied for most of the year, but competition or slower economic growth could reverse much of the increase of SNAP stock price.

7 Well-Positioned Oil Stocks in Today’s Trading Environment

These seven gas and oil stocks have fallen to low valuations and should have nowhere to go but up once pricing improves in the oil patch.

Can Tesla Supercharge Stock Gains After ‘Vanity Fair’ Article?

Doubts about Tesla's Solar Roof and related investments could weigh on both the reputation of Elon Musk and the performance of TSLA itself.

Expect the Transformation of Cronos Group to Change CRON Stock

For now, Cronos Group stock remains an extremely pricey marijuana play, despite its recent sharp losses. But in the long term, its backer Altria may mold and shape CRON into a cannabis version of itself.

FB Stock Will Thrive From Focusing on Its True Competition

Amid a low valuation and accusations from government agencies, FB stock will thrive if the company continues to focus in a certain area.

Wait for the Next Dip Before Jumping in on JD Stock

The earnings report proved that JD.com can thrive amid a trade war, but that same trade war could limit the upside of JD stock for now.